Jonathan D Paolino (Jonathan Paolino)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Combination Therapy

Allogeneic Hematopoietic Stem Cell Transplantation

Prognostic Factors

Drug Administration

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan D Paolino, Harrison K Tsai, Marian H Harris, Yana Pikman
IKZF1 Alterations and Therapeutic Targeting in B-Cell Acute Lymphoblastic Leukemia. Biomedicines 12 (1) (2024)
Jonathan D Paolino, Harrison K Tsai, Marian H Harris, Yana Pikman
IKZF1 Alterations and Therapeutic Targeting in B-Cell Acute Lymphoblastic Leukemia. Biomedicines 12 (1) (2024)
Jonathan D Paolino, Boris Dimitrov, Beth Apsel Winger, Angélica Sandoval-Pérez, Amith Vikram Rangarajan, Nicole Ocasio-Martinez, Harrison K Tsai, Yuting Li, Amanda L Robichaud, Delan Khalid, Charles Hatton, Riaz Gillani, Petri Polonen, Anthony Dilig, Giacomo Gotti, Julia Kavanagh, Asmani A Adhav, Sean Gow, Jonathan M Tsai, Yen-Der Li, Benjamin L Ebert, Eliezer Van Allen, Jacob R Bledsoe, Annette S Kim, Sarah K Tasian, Stacy L Cooper, Todd M Cooper, Nobuko Hijiya, Maria-Luisa Sulis, Neerav N Shukla, Jeffrey A Magee, Charles G Mullighan, Michael J Burke, Marlise R Luskin, Brenton G Mar, Matthew P Jacobson, Marian H Harris, Kimberly Stegmaier, Andrew E Place, Yana Pikman
Integration of genomic sequencing drives therapeutic targeting of PDGFRA in T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Shai Shimony, Yiwen Liu, Yannis K Valtis, Jonathan D Paolino, Andrew E Place, Andrew M Brunner, Lachelle Dawn Weeks, Lewis B Silverman, Lynda M Vrooman, Donna Neuberg, Richard M Stone, Daniel J DeAngelo, Marlise R Luskin
Nelarabine Combination Therapy for Relapsed or Refractory T-cell Acute Lymphoblastic Lymphoma/Leukemia. Blood advances (2022)
Shai Shimony, Yiwen Liu, Yannis K Valtis, Jonathan D Paolino, Andrew E Place, Andrew M Brunner, Lachelle Dawn Weeks, Lewis B Silverman, Lynda M Vrooman, Donna Neuberg, Richard M Stone, Daniel J DeAngelo, Marlise R Luskin
Nelarabine Combination Therapy for Relapsed or Refractory T-cell Acute Lymphoblastic Lymphoma/Leukemia. Blood advances (2022)
Jonathan D Paolino, Juliana Mariani, Alexandra Lucas, Jeremy Rupon, Howard Weinstein, Annah Abrams, Alison Friedmann
Outcomes of a clinical pathway for primary outpatient management of pediatric patients with low-risk febrile neutropenia. Pediatric blood & cancer 66 (7) (2019)